Market Intelligence Center  3 hrs ago  Comment 
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered-call trade on Sanofi-Aventis (SNY) that includes 4.05% downside protection. Sell one contract of the Dec....
Wall Street Journal  Oct 30  Comment 
Chris Viehbacher, who has lost his job as chief executive of French drug maker Sanofi SA, is entitled to receive a termination package of nearly 6 million euros ($7.6 million), according to company legal filings.
FiercePharma  Oct 30  Comment 
For the now-former chief of Sanofi, Chris Viehbacher, there's plenty of money for a cushion, but it won't be nearly as plump as the packages granted to his counterparts in the U.S.
FiercePharma  Oct 30  Comment 
Bernstein analyst Tim Anderson figures Sanofi would do well to look outside the company for its new CEO, like AstraZeneca did with its new-ish chief, Pascal Soriot. Well, Sanofi had a more literal view: The French drugmaker has contacted Soriot...
Reuters  Oct 30  Comment 
Events at Sanofi this week cost a high-flying German-Canadian boss his job and global investors billions. They are also a reminder that corporate France carries the national interest in its DNA, and neglects its family duties at its peril.
Benzinga  Oct 30  Comment 
On CNBC's Stock Pops & Drops, Karen Finerman said that she has a long position in Navios Maritime Acquisition Corporation (NYSE: NNA), which spiked 3.86 percent on Wednesday. Finerman picked this stock as her final trade on Tuesday and she still...
Benzinga  Oct 29  Comment 
Sanofi SA (ADR) (NYSE: SNY) was downgraded from Buy to Hold and had its price target reduced from €93 to €78 by Deutsche Bank on Wednesday. Analysts led by Mark Clark noted that the company cautioned that "sales in diabetes - its biggest...
FiercePharma  Oct 29  Comment 
When Sanofi announced that its franchise would suffer next year because of U.S. payer contracts, the natural follow-up question was this: Does this mean a diabetes pricing war? If Sanofi had to boost its rebates to win coverage--which the company...


Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki